 |
5 Diseases |  |
67 Trials |
|
67 Trials |  |
4266 News |  |
| «12...52535455565758596061626364» |
- |||| risperidone / Generic mfg.
Trial completion: CSP #504: Risperidone Treatment for Military Service Related Chronic Post Traumatic Stress Disorder (clinicaltrials.gov) - Aug 20, 2014
P2, N=296, Completed, Sponsor: Department of Veterans Affairs
Active, not recruiting --> Completed
- RO5545965 / Roche
Enrollment closed, Enrollment change: A Study of the Safety, Tolerability and Pharmacokientics of RO5545965 in Patients With Schizophrenia on Risperidone (clinicaltrials.gov) - Aug 12, 2014
P1, N=32, Active, not recruiting, Sponsor: Hoffmann-La Roche
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | N=48 --> 32
- risperidone / Generic mfg., paliperidone extended release / Generic mfg.
Trial primary completion date: A Study to Evaluate the Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function in Clinically Stable Patients With Schizophrenia (clinicaltrials.gov) - Aug 1, 2014
P4, N=50, Recruiting, Sponsor: Johnson & Johnson Taiwan Ltd
Recruiting --> Active, not recruiting | N=48 --> 32 Trial primary completion date: Jun 2014 --> Jun 2015
- | Biomarker, Phase classification: Metabolic Signatures and Biomarkers in Schizophrenia (clinicaltrials.gov) - Jul 27, 2014
P1, N=71, Completed, Sponsor: Duke University
Trial primary completion date: Jun 2014 --> Jun 2015 Phase classification: P4 --> P1
- Clinical: A Randomized Double-blind Trial With 6 Antipsychotic Drugs for Schizophrenia (clinicaltrials.gov) - Jul 17, 2014
P=N/A, N=550, Completed, Sponsor: Beijing Hui-Long-Guan Hospital
- paliperidone extended release / Generic mfg.
Trial termination: A Comparative Study of Patient Satisfaction Between Continued Administration of Previous Antipsychotics Versus Switched Administration to Paliperidone ER in Non-satisfied Patients With Previous Antipsychotic Drug (clinicaltrials.gov) - Jun 26, 2014
P4, N=13, Terminated, Sponsor: Janssen Korea, Ltd., Korea
Phase classification: P4 --> P1 Completed --> Terminated; This study was early terminated due to insufficient enrollment required for hypothesis testing.
- RO5545965 / Roche
Trial primary completion date: A Study of the Safety, Tolerability and Pharmacokientics of RO5545965 in Patients With Schizophrenia on Risperidone (clinicaltrials.gov) - Jun 26, 2014
P1, N=48, Recruiting, Sponsor: Hoffmann-La Roche
Completed --> Terminated; This study was early terminated due to insufficient enrollment required for hypothesis testing. Trial primary completion date: May 2014 --> Aug 2014
- risperidone / Generic mfg., desipramine / Generic mfg.
Enrollment closed: RADIAUS: Risperidone and Desipramine in Alcohol Use and Schizophrenia (clinicaltrials.gov) - Jun 18, 2014
P2, N=40, Active, not recruiting, Sponsor: Dartmouth-Hitchcock Medical Center
Trial primary completion date: May 2014 --> Aug 2014 Recruiting --> Active, not recruiting
- | risperidone / Generic mfg.
Phase classification, Review: Medical Chart Review of Patients on Long-term Treatment With Long-acting Injectable Risperidone (clinicaltrials.gov) - Jun 12, 2014
P4, N=342, Completed, Sponsor: Johnson & Johnson Taiwan Ltd
Recruiting --> Active, not recruiting Phase classification: P=N/A --> P4
- Trial primary completion date: IMPACT: Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics (clinicaltrials.gov) - May 14, 2014
P4, N=127, Completed, Sponsor: Johns Hopkins University
Phase classification: P=N/A --> P4 Trial primary completion date: Oct 2013 --> Mar 2014
- Trial completion date: IMPACT: Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics (clinicaltrials.gov) - May 14, 2014
P4, N=127, Completed, Sponsor: Johns Hopkins University
Trial primary completion date: Oct 2013 --> Mar 2014 Trial completion date: Apr 2014 --> Mar 2014
- Trial completion: IMPACT: Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics (clinicaltrials.gov) - May 14, 2014
P4, N=127, Completed, Sponsor: Johns Hopkins University
Trial completion date: Apr 2014 --> Mar 2014 Recruiting --> Completed
- ||| risperidone / Generic mfg., lurasidone / Generic mfg.
Enrollment open: A Clinical Trial of Lurasidone in Treatment of Schizophrenia (clinicaltrials.gov) - May 13, 2014
P=N/A, N=380, Recruiting, Sponsor: Sumitomo Pharmaceutical (Suzhou) Co., Ltd.
Recruiting --> Completed Not yet recruiting --> Recruiting
- Clinical: Antipsychotic to Treat Psychosis Syndrome (clinicaltrials.gov) - May 4, 2014
P=N/A, N=300, Recruiting, Sponsor: Central South University
- | citalopram / Generic mfg., risperidone / Generic mfg.
Trial completion: Treating Behavioral Disturbances in Individuals With Dementia (clinicaltrials.gov) - Apr 28, 2014
P2, N=137, Completed, Sponsor: University of Pittsburgh
Not yet recruiting --> Recruiting No longer recruiting --> Completed
- | risperidone / Generic mfg., trazodone ER / Generic mfg.
New P4 trial, Combination therapy, Monotherapy: Efficacy and Safety of Risperidone and Trazodone Monotherapy and Combination Therapy in Critically Ill Patients With Delirium (clinicaltrials.gov) - Apr 17, 2014
P4, N=128, Recruiting, Sponsor: Rochester General Hospital
- | risperidone / Generic mfg.
Trial completion: DSIR CT: Treatment of Autism in Children and Adolescents (clinicaltrials.gov) - Apr 15, 2014
P3, N=101, Completed, Sponsor: National Institute of Mental Health (NIMH)
No longer recruiting --> Completed No longer recruiting --> Completed
- | Trial completion: Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS) (clinicaltrials.gov) - Apr 9, 2014
P4, N=116, Completed, Sponsor: University of North Carolina, Chapel Hill
No longer recruiting --> Completed No longer recruiting --> Completed
- risperidone / Generic mfg.
Trial completion: Calcium and Vitamin D to Optimize Bone Mass in Boys With Risperidone-induced Hyperprolactinemia (clinicaltrials.gov) - Apr 1, 2014
P=N/A, N=51, Completed, Sponsor: University of Iowa
No longer recruiting --> Completed Recruiting --> Completed
- ||| Enrollment open: Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants (clinicaltrials.gov) - Mar 19, 2014
P1, N=265, Recruiting, Sponsor: Janssen Research & Development, LLC
Recruiting --> Completed Not yet recruiting --> Recruiting
- ||| New P1 trial: Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants (clinicaltrials.gov) - Mar 12, 2014
P1, N=265, Recruiting, Sponsor: Janssen Research & Development, LLC
- | paliperidone extended release / Generic mfg.
New P4 trial: Early Prediction of Clinical Response in Patients With Schizophrenia Treated by Paliperidone ER (clinicaltrials.gov) - Feb 27, 2014
P4, N=41, Completed, Sponsor: Taipei City Hospital
- risperidone / Generic mfg., olanzapine / Generic mfg.
Trial completion: The Effects of Risperidone and Olanzapine on Thinking (clinicaltrials.gov) - Feb 22, 2014
P4, N=0, Completed, Sponsor: Department of Veterans Affairs
Not yet recruiting --> Recruiting No longer recruiting --> Completed
- | risperidone / Generic mfg.
Trial completion: RUPP PI PDD: Drug and Behavioral Therapy for Children With Pervasive Developmental Disorders (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=124, Completed, Sponsor: Yale University
No longer recruiting --> Completed Active, not recruiting --> Completed
- |||| divalproex sodium XR / Generic mfg.
Trial completion: Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone in the Treatment of Schizophrenia (clinicaltrials.gov) - Feb 22, 2014
P2, N=400, Completed, Sponsor: Abbott
Active, not recruiting --> Completed No longer recruiting --> Completed
- | lithium carbonate ER / Generic mfg., risperidone / Generic mfg.
Trial completion: TEAM: Study of Outcome and Safety of Lithium, Divalproex and Risperidone for Mania in Children and Adolescents (clinicaltrials.gov) - Feb 22, 2014
P3, N=379, Completed, Sponsor: Washington University School of Medicine
No longer recruiting --> Completed Recruiting --> Completed
- risperidone / Generic mfg., olanzapine / Generic mfg., quetiapine / Generic mfg.
Trial completion: CAFE Comparison of Atypicals in First Episode of Psychosis (clinicaltrials.gov) - Feb 22, 2014
P3, N=0, Completed, Sponsor: AstraZeneca
Recruiting --> Completed No longer recruiting --> Completed
- | Trial completion: Treatment and Outcome of Early Onset Bipolar Disorder (clinicaltrials.gov) - Feb 22, 2014
P4, N=40, Completed, Sponsor: North Shore Long Island Jewish Health System
No longer recruiting --> Completed No longer recruiting --> Completed
- | lamotrigine liquid oral suspension / OWP Pharma
Trial completion: Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=5000, Completed, Sponsor: National Institute of Mental Health (NIMH)
No longer recruiting --> Completed No longer recruiting --> Completed
- | New P4 trial: Methylphenidate vs. Risperidone for the Treatment of Children and Adolescents With ADHD and Disruptive Disorders (clinicaltrials.gov) - Feb 13, 2014
P4, N=70, Recruiting, Sponsor: Sheba Medical Center
- |||| Invega Sustenna (paliperidone palmitate extended-release 1-month injection) / J&J
Trial completion: Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations (clinicaltrials.gov) - Feb 10, 2014
P4, N=1066, Completed, Sponsor: Janssen Scientific Affairs, LLC
No longer recruiting --> Completed Active, not recruiting --> Completed
- |||| Invega Sustenna (paliperidone palmitate extended-release 1-month injection) / J&J
Trial completion: 15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated (clinicaltrials.gov) - Feb 2, 2014
P4, N=453, Completed, Sponsor: Janssen Scientific Affairs, LLC
Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||| Vabicaserin (PF-05208769) / Pfizer
Trial completion: Study Evaluating Vabicaserin in Subjects With Schizophrenia (clinicaltrials.gov) - Feb 2, 2014
P2, N=199, Completed, Sponsor: Pfizer
Active, not recruiting --> Completed Terminated --> Completed
- Arvisol (cannabidiol) / Echo Pharma
New P1 trial, Preclinical: CBD-IS: Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study (clinicaltrials.gov) - Jan 29, 2014
P1, N=74, Recruiting, Sponsor: Central Institute of Mental Health, Mannheim
- Arvisol (cannabidiol) / Echo Pharma
Enrollment open, Preclinical: CBD-IS: Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study (clinicaltrials.gov) - Jan 29, 2014
P1, N=74, Recruiting, Sponsor: Central Institute of Mental Health, Mannheim
Terminated --> Completed Not yet recruiting --> Recruiting
- | Sediel (tandospirone) / Sumitomo Dainippon, Pfizer
New P4 trial: TAAS: Tandospirone Combined With Atypical Antipsychotic Drugs in Schizophrenia (clinicaltrials.gov) - Jan 16, 2014
P4, N=100, Not yet recruiting, Sponsor: Qingyun Yin
- RO5545965 / Roche
Enrollment open: A Study of the Safety, Tolerability and Pharmacokientics of RO5545965 in Patients With Schizophrenia on Risperidone (clinicaltrials.gov) - Jan 5, 2014
P1, N=48, Recruiting, Sponsor: Hoffmann-La Roche
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- Trial completion: Impulsivity and Thought Process Disorder in Patients With Active Suicidal Ideation and Depression (clinicaltrials.gov) - Jan 1, 2014
P=N/A, N=19, Completed, Sponsor: University of Alabama at Birmingham
Not yet recruiting --> Recruiting Enrolling by invitation --> Completed
- Serlect (sertindole) / Lundbeck, Abbott
New P4 trial: The Effect of Sertindole and Risperidone on Endophenotypic Markers of Schizophrenia (clinicaltrials.gov) - Dec 25, 2013
P4, N=1, Terminated, Sponsor: Birte Glenthoj
- | RO5545965 / Roche
New P1 trial: A Study of the Safety, Tolerability and Pharmacokientics of RO5545965 in Patients With Schizophrenia on Risperidone (clinicaltrials.gov) - Dec 22, 2013
P1, N=48, Recruiting, Sponsor: Hoffmann-La Roche
- | Enrollment closed: A Study to Evaluate the Efficacy and Safety of Risperidone (R064766) in Children and Adolescents With Irritability Associated With Autistic Disorder (clinicaltrials.gov) - Dec 15, 2013
P3, N=39, Active, not recruiting, Sponsor: Janssen Pharmaceutical K.K.
Enrolling by invitation --> Completed Recruiting --> Active, not recruiting
- | New P1 trial: Bioequivalence Test for Risperdal 2mg of Janssen Korea (clinicaltrials.gov) - Dec 12, 2013
P1, N=36, Completed, Sponsor: Janssen Korea, Ltd., Korea
- ||||||| risperidone / Generic mfg., blonanserin / Generic mfg.
Trial completion: Efficiency Study to Investigate Blonanserin in Treatment of Schizophrenia When Compared With Risperidone (clinicaltrials.gov) - Dec 1, 2013
P3, N=267, Completed, Sponsor: Sumitomo Pharmaceutical (Suzhou) Co., Ltd.
Recruiting --> Active, not recruiting Recruiting --> Completed
- |||| risperidone / Generic mfg., iloperidone / Generic mfg.
Trial completion: Efficacy and Safety Study of Iloperidone Virus Risperidone to Treat Schizophrenia (clinicaltrials.gov) - Nov 16, 2013
P2, N=260, Completed, Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Recruiting --> Completed Not yet recruiting --> Completed
- | risperidone / Generic mfg., olanzapine / Generic mfg., quetiapine / Generic mfg.
Trial completion, Combination therapy, Monotherapy: A Comparison of Two Standard Therapies in the Management of Dementia With Agitation (clinicaltrials.gov) - Nov 11, 2013
P4, N=50, Completed, Sponsor: Emory University
Not yet recruiting --> Completed Recruiting --> Completed
- |||| Caplyta (lumateperone) - Intra / Cellular Therapies
Trial completion: Study of a Novel Antipsychotic ITI-007 in Schizophrenia (clinicaltrials.gov) - Nov 8, 2013
P2, N=335, Completed, Sponsor: Intra-Cellular Therapies, Inc.
Recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic Episode (clinicaltrials.gov) - Oct 29, 2013
P3, N=159, Completed, Sponsor: University of British Columbia
Active, not recruiting --> Completed Not yet recruiting --> Completed
- risperidone / Generic mfg., clozapine / Generic mfg.
Enrollment change: Risperidone Augmentation in Patients With Schizophrenia (clinicaltrials.gov) - Oct 28, 2013
P4, N=24, Completed, Sponsor: Massachusetts General Hospital
Not yet recruiting --> Completed N=40 --> 24
- || New P3 trial: Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic Episode (clinicaltrials.gov) - Oct 21, 2013
P3, N=159, Completed, Sponsor: University of British Columbia
- risperidone / Generic mfg.
Enrollment change: Ginkgo Biloba Extract for Schizophrenia (clinicaltrials.gov) - Oct 14, 2013
P=N/A, N=124, Completed, Sponsor: Beijing Hui-Long-Guan Hospital
N=40 --> 24 N=200 --> 124